Clinical trials
Phase 1/2 trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 15 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 8 |
| Amgen | 4 |
| Gilead Sciences | 3 |
| AbbVie | 2 |
| Eli Lilly and Company | 2 |
| NanoCarrier Co., Ltd. | 2 |
| Novartis Pharmaceuticals | 2 |
| Academic Emergency County Hospital Sibiu | 1 |
| Astellas Pharma Europe B.V. | 1 |
| Astellas Pharma Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 6 |
| Small Cell Lung Carcinoma | 4 |
| Breast Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Arthritis, Rheumatoid | 2 |
| COVID-19 | 2 |
| Neoplasm Metastasis | 2 |
| Ovarian Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Acromegaly | 1 |
Trials
Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.